Preoperative Platelet and International Normalized Ratio Thresholds and Their Impact on Complications Following Revision Total Joint Arthroplasty
Arthroplasty Today · 24 Aug 2026
† Impact is the editorial-priority score. All scores are out of 100. Clinical is a stored clinical-importance score from the earlier method; it has not been recalculated.
Why it matters
Surgeons often use platelet and INR cutoffs to decide who is 'safe' for revision arthroplasty, and this study suggests those thresholds may be too lenient, particularly for infection and transfusion risk.
The evidence
This retrospective database study looked at patients undergoing revision total hip or knee arthroplasty and asked whether preoperative platelet counts and INR values below the traditional 'safe' thresholds (platelets ≥50,000/μL, INR <1.5) were linked to more complications. After propensity matching, patients with platelets 50,000-100,000/μL had nearly double the odds of needing a blood transfusion at 90 days (OR 1.88, 95% CI 1.45-2.44) along with higher odds of periprosthetic joint infection and 2-year mortality; mild INR elevation (1.1-1.5) and higher INR levels were also linked to more transfusions, thromboembolic events, infection, and in some groups mortality, though the risk did not rise in a clean stepwise fashion with higher INR.
Blood transfusion within 90 days: Odds ratio 1.88 (95% CI 1.45 to 2.44; units not reported). Interpret in the study's stated comparison; this alone does not establish a treatment's causal effect.
Why this rigour score?
Registry cohort (adjusted)Design starting point: 37.4
Raised the score
- Compared against current standard of care+3.4
- Aligned time zero+2.5
Lowered the score
- Only 1 months of follow-up−6.8
- Important imbalance remained after adjustment−5.1
Methods at a glance
Recorded assessment- Confounding adjustmentPropensity scores
- Covariate balance confirmedNot met
- Outcome assessors blindedNot applicable
- Comparable start of follow-upMet
- Adequate statistical powerNot reported
- Prospective registrationNot met
Not reported does not mean not done. Checks have different weights; this is not a count of boxes ticked.
See the full score breakdown
- Study design starting point
- 37.4
- Important imbalance remained after adjustment
- −5.1
- Aligned time zero
- +2.5
- Compared against current standard of care
- +3.4
- Validated coding algorithm
- +2.5
- Only 1 months of follow-up
- −6.8
- No correction for multiple comparisons
- −3.4
- Journal prior (not an observed method)
- +0.8
- Final rigour score rounded
- 31 / 100
Study design sets the starting point and a ceiling of 80. Recorded methods then adjust the score. Points are shown to one decimal place; the final score uses unrounded values.
Checklist from the stored appraisal. “Not met” describes the recorded criterion; it does not always produce a deduction. This overview supports reading the full study.
For journal club
1.Should surgeons delay or further optimize revision arthroplasty candidates with platelet counts between 100,000 and 150,000/μL, a range currently considered 'normal' but here linked to higher transfusion, PJI, and mortality risk?
2.Given that INR elevations above 1.5 did not show a stepwise increase in complications, how should surgeons weigh the risks of interrupting anticoagulation for reversal versus proceeding with a mildly elevated INR in revision arthroplasty patients?
Original publication title
Preoperative Platelet and International Normalized Ratio Thresholds and Their Impact on Complications Following Revision Total Joint Arthroplasty